Steven Cohen's DNTH Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 643,599 shares of Dianthus Therapeutics, Inc. (DNTH) worth $54.01 M, representing 0.07% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in DNTH, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 1.29 M shares. Largest reduction occurred in Q4 2025, reducing 875,872 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Dianthus Therapeutics (DNTH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dianthus Therapeutics (DNTH) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -522,489 | Reduce 44.81% | 643,599 | $83.92 |
| Q4 2025 | -875,872 | Reduce 42.89% | 1.17 M | $41.21 |
| Q3 2025 | +649,443 | Add 46.64% | 2.04 M | $39.35 |
| Q2 2025 | -94,427 | Reduce 6.35% | 1.39 M | $18.63 |
| Q1 2025 | +1.29 M | Add 668.05% | 1.49 M | $18.14 |
| Q4 2024 | -244,100 | Reduce 55.77% | 193,600 | $21.80 |
| Q3 2024 | +263,500 | Add 151.26% | 437,700 | $27.38 |
| Q2 2024 | -177,900 | Reduce 50.53% | 174,200 | $25.88 |
| Q1 2024 | +352,100 | New Buy | 352,100 | $30.00 |
Steven Cohen's Dianthus Therapeutics Investment FAQs
Steven Cohen first purchased Dianthus Therapeutics, Inc. (DNTH) in Q1 2024, acquiring 352,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Dianthus Therapeutics, Inc. (DNTH) for 9 quarters since Q1 2024.
Steven Cohen's largest addition to Dianthus Therapeutics, Inc. (DNTH) was in Q1 2025, adding 1,486,944 shares worth $26.97 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 643,599 shares of Dianthus Therapeutics, Inc. (DNTH), valued at approximately $54.01 M.
As of the Q1 2026 filing, Dianthus Therapeutics, Inc. (DNTH) represents approximately 0.07% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Dianthus Therapeutics, Inc. (DNTH) was 2,041,960 shares, as reported at the end of Q3 2025.